FIELD: medicine.
SUBSTANCE: method for inducing cell death of a cell having BRAF gene mutation, a method for suppressing cell growth of a cell having BRAF gene mutation, the application of a drug suppressing GST-π production for the treatment of cancer caused by cell growth defect, and the application of a drug suppressing GST-π production and BRAF inhibitor for the treatment of cancer caused by growth defect of a cell having BRAF gene mutation are proposed. A method for screening a drug for inducing cell death of a cell having BRAF gene mutation, and a method for screening a drug for suppressing cell growth of a cell having BRAF gene mutation are proposed.
EFFECT: proposed group of inventions provides for inducing cell death and suppressing cell growth of a cell having BRAF gene mutation.
10 cl, 6 dwg, 3 ex
Title |
Year |
Author |
Number |
AGENT INDUCING CELL DEATH, CELL GROWTH INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE CAUSED BY ABNORMAL CELL GROWTH |
2015 |
- Niitsu Yoshiro
- Minomi Kenjirou
- Tanaka Hiroyuki
|
RU2707746C2 |
APOPTOSIS-INDUCING MEANS |
2011 |
- Niitsu Joshiro
- Nishita Khiroki
|
RU2639459C2 |
BRAF MUTATIONS ENSUING RESISTANCE TO BRAF INHIBITORS |
2011 |
- Garrauehj Levi
- Ehmeri Kehrolajn
|
RU2571930C2 |
APILIMOD COMPOSITIONS AND METHODS OF USING THEM IN TREATING COLORECTAL CANCER |
2015 |
- Bikharri Nil
- Gejl Sofiya
- Landrette Shon
- Bekett Pol
- Konrad Kris
- Syuj Tyan
- Ernandes Marilens
- Rotberg Dzhonatan M.
- Likhenshtejn Khenri
|
RU2739992C2 |
METHOD OF TREATING GEFITINIB-RESISTANT CANCER |
2006 |
- Khaber Dehniel
- Bell Dafis Uinifred
- Settlmehn Dzheffri E.
- Sordella Raffaehlla
- Goudin-Khejmann Nadja Dzh.
- Kvak Junis L.
- Rabindran Sridkhar Krishna
|
RU2405566C9 |
DETERMINATION OF CELL SENSITIVITY TO TREATMENT WITH B-Raf INHIBITOR BY DETECTION OF K-ras MUTATION AND LEVELS OF RTK EXPRESSION |
2010 |
- Khatzivassiliu Dzhordzhija
- Malek Shiva
|
RU2553379C2 |
NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR |
2002 |
|
RU2316591C2 |
COMBINED THERAPY PAC-1 |
2016 |
- Hergenrother Paul J.
- Peh Jessie
|
RU2720509C2 |
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION |
2002 |
- Ferrandi Ehrik
- Kamara I Ferrer Khose-Antonio
- Martine Zhan
- Tjur'O Kristof
|
RU2307666C2 |
N-(3-(5-(4-CHLOROPHENYL)-1N-PYRAZOLO[3,4-B]PYRIDINE-3-CARBONYL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULPHONAMIDE CRYSTALLINE FORM, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION AND MEDICINE |
2018 |
- Leonov Sergej Viktorovich
- Chuprov-Netochin Roman Nikolaevich
- Ivanenkov Yan Andreevich
|
RU2678455C1 |